We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+4.45%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$24.5B
AUM Growth
-$766M
(-3%)
Cap. Flow
+$1.16B
Cap. Flow
% of AUM
4.71%
Top 10 Holdings %
Top 10 Hldgs %
14.99%
Holding
4,039
New
907
Increased
1,143
Reduced
1,068
Closed
874
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$208M |
| 2 |
CVS Health
CVS
|
+$132M |
| 3 |
Comcast
CMCSA
|
+$114M |
| 4 |
Honeywell
HON
|
+$94.8M |
| 5 |
ConocoPhillips
COP
|
+$92.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$233M |
| 2 |
iShares China Large-Cap ETF
FXI
|
+$228M |
| 3 |
Apple
AAPL
|
+$195M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$157M |
| 5 |
Nike
NKE
|
+$132M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.7% |
| 2 | Consumer Discretionary | 10.58% |
| 3 | Healthcare | 6.83% |
| 4 | Industrials | 5.75% |
| 5 | Financials | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NNDM
3051
Nano Dimension
NNDM
$309M
| $52K | ﹤0.01% |
17,990
-3,095
| -15% | -$8.32K |
|
3052
Goldgroup Mining Inc.
GORO
$151M
| $51.8K | ﹤0.01% |
+49,363
| New | +$63.1K |
|
3053
BioAtla
BCAB
$5.59M
| $51.4K | ﹤0.01% |
384
+85
| +28% | +$15.3K |
|
|
CURO
3054
DELISTED
CURO Group Holdings Corp.
CURO
| $51.4K | ﹤0.01% |
29,692
-13,694
| -32% | -$44.5K |
|
3055
Cadiz
CDZI
$266M
| $50.7K | ﹤0.01% |
+12,541
| New | +$50.6K |
|
|
PHLT
3056
DELISTED
Performant Healthcare Inc
PHLT
| $50.6K | ﹤0.01% |
+14,879
| New | +$48.7K |
|
|
MRSN
3057
DELISTED
Mersana Therapeutics
MRSN
| $50.3K | ﹤0.01% |
489
-3,413
| -87% | -$479K |
|
3058
Neuronetics
STIM
$120M
| $50.2K | ﹤0.01% |
+17,253
| New | +$87K |
|
3059
Clean Energy Fuels
CLNE
$447M
| $50.2K | ﹤0.01% |
11,509
-280,473
| -96% | -$1.45M |
|
3060
Inseego
INSG
$108M
| $50.1K | ﹤0.01% |
8,608
+2,680
| +45% | +$23.8K |
|
3061
Arteris
AIP
$1.4B
| $50K | ﹤0.01% |
+11,832
| New | +$61.9K |
|
3062
Pagaya Technologies
PGY
$1.32B
| $49.7K | ﹤0.01% |
4,057
+1,702
| +72% | +$22.1K |
|
|
RBOT
3063
DELISTED
Vicarious Surgical
RBOT
| $49.5K | ﹤0.01% |
726
-93
| -11% | -$7.23K |
|
3064
Lineage Cell Therapeutics
LCTX
$257M
| $49.3K | ﹤0.01% |
+32,856
| New | +$45.9K |
|
3065
Karyopharm Therapeutics
KPTI
$168M
| $48.8K | ﹤0.01% |
837
-2,649
| -76% | -$131K |
|
3066
PUT
Opendoor
OPEN
$3.7B
| $47.2K | ﹤0.01% |
+27,693
| New | +$45.6K |
|
|
3067
CALL
Opendoor
OPEN
$3.7B
| $47K | ﹤0.01% |
27,590
-127,410
| -82% | -$210K |
|
3068
SoundHound AI
SOUN
$2.68B
| $46.1K | ﹤0.01% |
+16,696
| New | +$39.3K |
|
3069
Comscore
SCOR
$110M
| $44.8K | ﹤0.01% |
+1,822
| New | +$44.3K |
|
|
ZH
3070
Zhihu
ZH
$270M
| $44.3K | ﹤0.01% |
5,812
-4,103
| -41% | -$38K |
|
3071
Stereotaxis
STXS
$129M
| $44.1K | ﹤0.01% |
+21,628
| New | +$48.6K |
|
|
RJET
3072
Republic Airways Holdings
RJET
$810M
| $43.1K | ﹤0.01% |
+1,213
| New | +$50.7K |
|
|
LONA
3073
LeonaBio Inc
LONA
$69.4M
| $42.2K | ﹤0.01% |
1,688
-33
| -2% | -$1.06K |
|
|
CBD
3074
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $41.8K | ﹤0.01% |
14,232
-27,047
| -66% | -$87.7K |
|
3075
Instil Bio
TIL
$48.4M
| $41.2K | ﹤0.01% |
3,117
-25,019
| -89% | -$370K |
|
Similar funds
Squarepoint's Q1 2023 Portfolio in Review
As of Q1 2023, Squarepoint held 4,039 positions worth $24.5B, down 3% from $25.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Squarepoint deployed $1.16B of net new capital in Q1 2023, opening 907 new positions and adding to 1,143 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,782,957 shares worth $210M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was State Street Materials Select Sector SPDR ETF, an estimated $233M trimmed.
- Squarepoint's largest Q1 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,782,957 shares worth $210M.
- Squarepoint added most to CVS Health in Q1 2023, an estimated $132M increase.
- Squarepoint's biggest Q1 2023 reduction was State Street Materials Select Sector SPDR ETF, cutting an estimated $233M.
- Squarepoint fully exited Mondelez International in Q1 2023, selling an estimated $95.9M.
- Squarepoint's ten largest holdings make up 15% of its $24.5B portfolio in Q1 2023.
- Squarepoint opened 907 new positions and closed 874 in Q1 2023.
- Squarepoint's portfolio value fell 3% quarter-over-quarter to $24.5B.
Based on Squarepoint's 13F filing for Q1 2023, filed 15 May 2023.